Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
30 August 2017 09:07
A new drug may carry a boost for heart attack and cancer patients
A study has discovered that a new drug could help cut cancer deaths, as well as potentially reduce the risk of heart attacks.
More than 10,000 patients, all of whom had previously had a heart attack but had not been diagnosed with cancer, took part in a trial using the anti-inflammatory Canakinumab.
They were treated once every three months and monitored for four years.
Milestone in a long journey
It was found that there was a 15% reduction in the risk of heart attacks and strokes, while cancer deaths were cut in half.
Commenting on the study, which was presented at the European Society of Cardiology meeting in Barcelona, Dr Paul Ridker of Brigham and Women's Hospital in Boston said it "represents a milestone in a long journey".
"For the first time, we've been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk," he said.
"This has far-reaching implications. It tells us that by leveraging an entirely new way to treat patients - targeting inflammation - we may be able to significantly improve outcomes for certain very high-risk populations."
He added that further research is needed into the drug's effects on cancer.
A platform for the future
Gary Gibbons, director of the National Heart, Lung and Blood Institute, said the results provide a platform on which to carry out further trials and research.
He added that while the trial offers "compelling evidence" that targeting inflammation efficacy is preventing recurrent cardiovascular events, the Institute is also looking forward to findings from additional trials, including the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to help further refine the best therapeutic strategies for preventing heart disease.
People who have undergone cancer treatment in the past can arrange specialist medical travel insurance when taking holidays.
17 April 2018
Despite its reputation as a party drug, ketamine is licensed as an anaesthetic. A recent US study found use of the drug via a nasal spray led to "significant" improvements in depressive symptoms in the first 24 hours.
[more...]
Simple brain-training exercises carried out at home have been shown to reduce emotional stress in female breast cancer survivors, it's recently been revealed.
13 April 2018
Drinkers who consume more alcohol than UK guidelines suggest could be cutting years off their lives, according to new research.
12 April 2018
A recent study has revealed that people who sustain brain injuries are at an increased risk of developing dementia later in life.
11 April 2018
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
07 April 2018
The Philippines is set to shut its most famous holiday island of Boracay for six months, after the President described it as a "cesspool".
05 April 2018
Taxes on soft drinks, alcohol and tobacco - nicknamed "sin taxes" - could be a powerful step towards combating rising rates of chronic diseases worldwide, research has suggested.
New "one-stop shops" to speed up cancer diagnosis are being trialled across the country for the first time.
30 March 2018
Doctors should tell patients that e-cigarettes are less harmful than smoking but not without risk, according to new national guidance.
29 March 2018
Young people suffering from mental health problems are finding it hard to get the support they need, a survey has revealed.
28 March 2018
Children exposed to epilepsy drugs in the womb may achieve poorer test results at school, a study has suggested.
27 March 2018
Air pollution is responsible for nearly 40% of childhood asthma cases in Bradford, a city which was at the centre of the Industrial Revolution, a study has found.